Thu, June 15, 2023

Yatin Suneja Reiterated (AXSM) at Strong Buy and Held Target at $110 on, Jun 15th, 2023

Yatin Suneja of Guggenheim, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $110 on, Jun 15th, 2023.

Yatin has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Yatin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $90 on, Monday, June 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Yatin


  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $95 on, Wednesday, June 14th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $200 on, Thursday, May 11th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $104 on, Tuesday, May 9th, 2023